Nanobiotix (NBTX) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Nanobiotix, a late-stage clinical biotechnology company, has disclosed its updated total number of voting rights and outstanding shares as required by French law. The company, known for its innovative therapeutic approaches in oncology and other medical fields, has a strong intellectual property portfolio with over 25 patent families. Listed on both the Euronext Paris and Nasdaq, Nanobiotix maintains a commitment to expanding human life possibilities through its advanced technology platforms.
For further insights into NBTX stock, check out TipRanks’ Stock Analysis page.
